210 related articles for article (PubMed ID: 16456542)
1. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
[TBL] [Abstract][Full Text] [Related]
2. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
3. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity.
Maudsley S; Zamah AM; Rahman N; Blitzer JT; Luttrell LM; Lefkowitz RJ; Hall RA
Mol Cell Biol; 2000 Nov; 20(22):8352-63. PubMed ID: 11046132
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
6. Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF.
Demoulin JB; Seo JK; Ekman S; Grapengiesser E; Hellman U; Rönnstrand L; Heldin CH
Biochem J; 2003 Dec; 376(Pt 2):505-10. PubMed ID: 12967325
[TBL] [Abstract][Full Text] [Related]
7. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
[TBL] [Abstract][Full Text] [Related]
8. NHERF2 increases platelet-derived growth factor-induced proliferation through PI-3-kinase/Akt-, ERK-, and Src family kinase-dependent pathway.
Jung Kang Y; Su Jeon E; Jin Lee H; Oh YS; Suh PG; Sup Jung J; Donowitz M; Ho Kim J
Cell Signal; 2004 Jul; 16(7):791-800. PubMed ID: 15115658
[TBL] [Abstract][Full Text] [Related]
9. A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration.
James MF; Beauchamp RL; Manchanda N; Kazlauskas A; Ramesh V
J Cell Sci; 2004 Jun; 117(Pt 14):2951-61. PubMed ID: 15161943
[TBL] [Abstract][Full Text] [Related]
10. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
[TBL] [Abstract][Full Text] [Related]
11. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the PDZ1 domain of human Na(+)/H(+) exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class I PDZ domains.
Karthikeyan S; Leung T; Birrane G; Webster G; Ladias JA
J Mol Biol; 2001 May; 308(5):963-73. PubMed ID: 11352585
[TBL] [Abstract][Full Text] [Related]
13. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
[TBL] [Abstract][Full Text] [Related]
14. Expression of NHERF-1, NHERF-2, PDGFR-alpha, and PDGFR-beta in normal human kidneys and in renal transplant rejection.
Weinman EJ; Lakkis J; Akom M; Wali RK; Drachenberg CB; Coleman RA; Wade JB
Pathobiology; 2002-2003; 70(6):314-23. PubMed ID: 12865627
[TBL] [Abstract][Full Text] [Related]
15. PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.
Conley-LaComb MK; Huang W; Wang S; Shi D; Jung YS; Najy A; Fridman R; Bonfil RD; Cher ML; Chen YQ; Kim HC
Am J Pathol; 2012 Mar; 180(3):1017-1027. PubMed ID: 22209699
[TBL] [Abstract][Full Text] [Related]
16. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.
Zhang H; Bajraszewski N; Wu E; Wang H; Moseman AP; Dabora SL; Griffin JD; Kwiatkowski DJ
J Clin Invest; 2007 Mar; 117(3):730-8. PubMed ID: 17290308
[TBL] [Abstract][Full Text] [Related]
17. Roles for NHERF1 and NHERF2 on the regulation of C3a receptor signaling in human mast cells.
Subramanian H; Gupta K; Ali H
PLoS One; 2012; 7(12):e51355. PubMed ID: 23284683
[TBL] [Abstract][Full Text] [Related]
18. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
19. Modulatory roles of NHERF1 and NHERF2 in cell surface expression of the glutamate transporter GLAST.
Sato K; Otsu W; Otsuka Y; Inaba M
Biochem Biophys Res Commun; 2013 Jan; 430(2):839-45. PubMed ID: 23200831
[TBL] [Abstract][Full Text] [Related]
20. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
